Zobrazeno 1 - 10 of 3 360 pro vyhledávání: '"Pottier C."'
3
Akademický článek
Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI
Autor: Brochet, B., Casey, R., Cotton, F., De Sèze, J., Douek, P., Guillemin, F., Laplaud, D., Lebrun-Frenay, C., Mansuy, L., Moreau, T., Olaiz, J., Pelletier, J., Rigaud-Bully, C., Stankoff, B., Vukusic, S., Marignier, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., Collongues, N., Lubetzki, C., Vermersch, P., Labauge, P., Defer, G., Cohen, M., Fromont, A., Wiertlewsky, S., Berger, E., Clavelou, P., Audoin, B., Giannesini, C., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Créange, A., Camdessanché, J.-P., Faure, J., Maurousset, A., Patry, I., Hankiewicz, K., Pottier, C., Maubeuge, N., Labeyrie, C., Nifle, C., Ameli, R., Anxionnat, R., Attye, A., Bannier, E., Barillot, C., Ben Salem, D., Boncoeur-Martel, M.-P., Bonneville, F., Boutet, C., Brisset, J.-C., Cervenanski, F., Claise, B., Commowick, O., Constans, J.-M., Dardel, P., Desal, H., Dousset, Vincent, Durand-Dubief, F., Ferre, J.-C., Gerardin, E., Glattard, T., Grand, S., Grenier, T., Guillevin, R., Guttmann, C., Krainik, A., Kremer, S., Lion, S., Menjot de Champfleur, N., Mondot, L., Outteryck, O., Pyatigorskaya, N., Pruvo, J.-P., Rabaste, S., Ranjeva, J.-P., Roch, J.-A., Sadik, J.C., Sappey-Marinier, D., Savatovsky, J., Tanguy, J.-Y., Tourbah, A., Tourdias, T., Roca, P., Colas, L., Tucholka, A., Rubini, P., Cackowski, S., Ding, J., Budzik, J.-F., Renard, F., Doyle, S., Barbier, E.L., Bousaid, I., Lassau, N., Verclytte, S.
Publikováno v: In Diagnostic and Interventional Imaging December 2020 101(12):795-802
Zobrazit plný text záznamu
4
Akademický článek
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
Autor: Gavoille A; Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, France.; Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Évolutive UMR 5558, Villeurbanne, France.; Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, Lyon, France., Rollot F; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, l'Institut national de la santé et de la recherche médicale 1028 et CNRS UMR 5292, Lyon, France.; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Casey R; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, l'Institut national de la santé et de la recherche médicale 1028 et CNRS UMR 5292, Lyon, France.; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Kerbrat A; CHU Pontchaillou, CIC1414 l'Institut national de la santé et de la recherche médicale, Rennes, France., Le Page E; CHU Pontchaillou, CIC1414 l'Institut national de la santé et de la recherche médicale, Rennes, France., Bigaut K; Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, CIC1434, l'Institut national de la santé et de la recherche médicale 1434, Strasbourg, France., Mathey G; Department of Neurology, Nancy University Hospital, Nancy, France. Université de Lorraine, APEMAC, Nancy, France., Michel L; CHU Pontchaillou, CIC1414 l'Institut national de la santé et de la recherche médicale, Rennes, France., Ciron J; Department of Neurology, CHU de Toulouse, CRC-SEP, Toulouse Cedex 9, France.; Université Toulouse III, Infinity, l'Institut national de la santé et de la recherche médicale UMR1291 - CNRS UMR 5051, Toulouse Cedex 3, France., Ruet A; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France.; Neurocentre Magendie, Bordeaux University, l'Institut national de la santé et de la recherche médicale U1215, Bordeaux, France., Maillart E; Département de neurologie, Hôpital Pitié-Salpêtrière, APHP, Paris, Centre de Ressources et de Compétences SEP, Paris, France., Labauge P; CHU de Montpellier, MS Unit, Montpellier Cedex 5, France.; University of Montpellier, Montpellier, France., Zephir H; CHU Lille, CRC-SEP Lille, Univ Lille, U1172, Lille, France., Papeix C; Department of Neurology, Fondation Rothschild, Paris, France., Defer G; Department of Neurology, CHU de Caen, MS expert centre, avenue de la Côte-de-Nacre, Normandy University, Caen, France., Lebrun-Frenay C; Neurology, UR2CA_URRIS, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France., Moreau T; Department of Neurology, CHU de Dijon, EA4184, Dijon, France., Berger E; CHU de Besançon, Service de Neurologie Besançon, France., Stankoff B; Sorbonne Universités, UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de la Pitié Salpêtrière, l'Institut national de la santé et de la recherche médicale UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine hospital, Paris, France., Clavelou P; Department of Neurology, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Université Clermont Auvergne, l'Institut national de la santé et de la recherche médicale, Neuro-Dol, Clermont-Ferrand, France., Thouvenot E; Université Clermont Auvergne, l'Institut national de la santé et de la recherche médicale, Neuro-Dol, Clermont-Ferrand, France.; Department of Neurology, Nimes University Hospital, Nimes Cedex 9, France., Heinzlef O; Department of Neurology, Hôpital de Poissy, Poissy, France., Pelletier J; Aix Marseille Univ, APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, Marseille, France., Al-Khedr A; Department of Neurology, CHU d'Amiens, Amiens, France., Casez O; Department of Neurology, CHU Grenoble Alpes, Neurology MS Clinic Grenoble, Grenoble Alpes university hospital, Grenoble, La Tronche, France.; T-RAIG, TIMC-IMAG, Grenoble Alpes University, France., Bourre B; Department of Neurology, CHU de Rouen, Rouen, France., Cabre P; Department of Neurology, CHU de la Martinique, Fort-de-France, France., Wahab A; Department of Neurology, APHP, Hôpital Henri Mondor, Créteil, France., Magy L; Department of Neurology, CHU de Limoges, Hôpital Dupuytren, Limoges, France., Camdessanché JP; Department of Neurology, CHU de Saint-Étienne, Hôpital Nord, Saint-Étienne, France., Doghri I; Department of Neurology, and CHU de Tours, Hôpital Bretonneau, CRC-SEP Tours, France., Moulin S; Department of Neurology, CHU de Reims, CRC-SEP, F-51092 Reims Cedex, France., Ben-Nasr H; Department of Neurology, Hôpital Sud Francilien, Corbeil Essonnes, France., Labeyrie C; Department of Neurology, CHU Bicêtre, Le Kremlin Bicêtre, France., Hankiewicz K; Department of Neurology, Hôpital Pierre Delafontaine, Centre Hospitalier de Saint-Denis, Saint-Denis, France., Neau JP; Department of Neurology, CHU la Milétrie, Hôpital Jean Bernard, Poitiers, France., Pottier C; Department of Neurology, CH de Pontoise, Hôpital René Dubos, Pontoise, France., Nifle C; Department of Neurology, Centre Hospitalier de Versailles, Le Chesnay, France., Manchon E; Department of Neurology, CH de Gonesse, Gonesse, France., Lapergue B; Department of Neurology, Hôpital Foch, Suresnes, France., Wiertlewski S; Nantes Université, l'Institut national de la santé et de la recherche médicale, CHU de Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, CIC l'Institut national de la santé et de la recherche médicale 1413, Service de Neurologie, Nantes, France., De Sèze J; Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, CIC1434, l'Institut national de la santé et de la recherche médicale 1434, Strasbourg, France., Vukusic S; Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, France.; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, l'Institut national de la santé et de la recherche médicale 1028 et CNRS UMR 5292, Lyon, France.; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; EDMUS Foundation Against Multiple Sclerosis Bron Cedex, France., Laplaud DA; Nantes Université, l'Institut national de la santé et de la recherche médicale, CHU de Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, CIC l'Institut national de la santé et de la recherche médicale 1413, Service de Neurologie, Nantes, France.
Publikováno v: JAMA neurology [JAMA Neurol] 2024 Aug 01; Vol. 81 (8), pp. 814-823.
Zobrazit plný text záznamu
5
Akademický článek
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing.
Autor: Pottier C, Küçükali F, Baker M, Batzler A, Jenkins GD, van Blitterswijk M, Vicente CT, De Coster W, Wynants S, Van de Walle P, Ross OA, Murray ME, Faura J, Haggarty SJ, van Rooij JG, Mol MO, Hsiung GR, Graff C, Öijerstedt L, Neumann M, Asmann Y, McDonnell SK, Baheti S, Josephs KA, Whitwell JL, Bieniek KF, Forsberg L, Heuer H, Lago AL, Geier EG, Yokoyama JS, Oddi AP, Flanagan M, Mao Q, Hodges JR, Kwok JB, Domoto-Reilly K, Synofzik M, Wilke C, Onyike C, Dickerson BC, Evers BM, Dugger BN, Munoz DG, Keith J, Zinman L, Rogaeva E, Suh E, Gefen T, Geula C, Weintraub S, Diehl-Schmid J, Farlow MR, Edbauer D, Woodruff BK, Caselli RJ, Donker Kaat LL, Huey ED, Reiman EM, Mead S, King A, Roeber S, Nana AL, Ertekin-Taner N, Knopman DS, Petersen RC, Petrucelli L, Uitti RJ, Wszolek ZK, Ramos EM, Grinberg LT, Gorno Tempini ML, Rosen HJ, Spina S, Piguet O, Grossman M, Trojanowski JQ, Keene DC, Lee-Way J, Prudlo J, Geschwind DH, Rissman RA, Cruchaga C, Ghetti B, Halliday GM, Beach TG, Serrano GE, Arzberger T, Herms J, Boxer AL, Honig LS, Vonsattel JP, Lopez OL, Kofler J, White CL, Gearing M, Glass J, Rohrer JD, Irwin DJ, Lee EB, Van Deerlin V, Castellani R, Mesulam MM, Tartaglia MC, Finger EC, Troakes C, Al-Sarraj S, Miller BL, Seelaar H, Graff-Radford NR, Boeve BF, Mackenzie IR, van Swieten JC, Seeley WW, Sleegers K, Dickson DW, Biernacka JM, Rademakers R
Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.
Zobrazit plný text záznamu
6
Akademický článek
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
Autor: Kouri N; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Frankenhauser I; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.; Paracelsus Medical Private University, Salzburg, Austria., Peng Z; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Labuzan SA; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Boon BDC; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Moloney CM; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Pottier C; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Wickland DP; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Caetano-Anolles K; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Corriveau-Lecavalier N; Department of Radiology, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Tranovich JF; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Wood AC; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Hinkle KM; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Lincoln SJ; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Spychalla AJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Senjem ML; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Przybelski SA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Engelberg-Cook E; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Schwarz CG; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Kwan RS; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Lesser ER; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Crook JE; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Carter RE; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida., Ross OA; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Lachner C; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida., Ertekin-Taner N; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.; Department of Neurology, Mayo Clinic, Jacksonville, Florida., Ferman TJ; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida., Fields JA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Ramanan VK; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Nguyen AT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Reichard RR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Jones DT; Department of Radiology, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Graff-Radford J; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Boeve BF; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Knopman DS; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Petersen RC; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Jack CR Jr; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Kantarci K; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Day GS; Department of Neurology, Mayo Clinic, Jacksonville, Florida., Duara R; Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, Florida., Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, Florida., Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida., Lowe VJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Vemuri P; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Publikováno v: JAMA neurology [JAMA Neurol] 2024 Jun 01; Vol. 81 (6), pp. 619-629.
Zobrazit plný text záznamu
7
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
Autor: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C. C., Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E
Publikováno v: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand’Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8
BMC Medical Research Methodology
BMC Medical Research Methodology, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
BMC Medical Research Methodology, BioMed Central, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8
Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing-remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control treatment in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76c9aa3b89340f07462e048e392906e
https://avesis.deu.edu.tr/publication/details/fef052b9-7e13-4a9f-b86e-a900c3dd0924/oai
Zobrazit plný text záznamu
8
Identification, Prevalence and Susceptibility Profile of Candida Isolates at the Pasteur Institute in Côte D'ivoire from 2017 to 2019
Autor: Bonouman Ira A.V., Mboh R., Roger F., Krasteva D., Bellet V., Koffi D., Noell J., Pottier C., Drakulovski P., Menan H., Toure O., Dosso M., Ranque S., Bertout S.
Publikováno v: African Journal of Biology and Medical Research. 6:1-16
This study was conducted in Côte d’Ivoire to determine the respective prevalence of Candida species and to study their susceptibility profile to antifungal agents to identify the emergence of resistance.This retrospective study was conducted from
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90f145075ca616565a660cdd393c9f13
https://doi.org/10.52589/ajbmr-3ffy5hwh
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje